Other psychoactive substance related disorders
Chapter 5:Mental, Behavioral and Neurodevelopmental disorders
ICD-10 F19 is a billable code used to indicate a diagnosis of other psychoactive substance related disorders.
F19 encompasses a range of disorders related to the use of psychoactive substances that do not fall under the more specific categories of substance use disorders. This includes conditions resulting from the use of substances such as hallucinogens, inhalants, and other non-specific psychoactive agents. Patients may present with symptoms of intoxication, withdrawal, or substance use disorders characterized by a pattern of compulsive use despite adverse consequences. The clinical picture can vary widely, from mild impairment to severe addiction, and may include physical, psychological, and social dysfunction. Treatment often involves a combination of behavioral therapies, counseling, and, in some cases, pharmacotherapy to manage withdrawal symptoms or cravings. Accurate diagnosis and coding are crucial for effective treatment planning and reimbursement processes.
Detailed substance use history, treatment plans, and progress notes.
Patients presenting with withdrawal symptoms, relapse prevention, and ongoing management of substance use disorders.
Ensure documentation reflects the severity of the disorder and any co-occurring mental health issues.
Comprehensive psychiatric evaluations, including mental status exams and risk assessments.
Patients with dual diagnoses of substance use and mental health disorders.
Accurate documentation of the relationship between substance use and psychiatric symptoms is crucial.
Used when assessing a patient with suspected psychoactive substance use disorder.
Document the assessment findings and treatment recommendations.
Ensure the assessment aligns with the diagnosis for accurate billing.
F19 includes disorders related to the use of various psychoactive substances not specifically classified elsewhere, such as hallucinogens, inhalants, and other non-specific agents.
F19 is used when the specific substance is unknown or when the disorder does not fit into the defined categories of other substance use disorders. Always document the specifics of the substance used when possible.
